“Blue letter effects”: Changes in physicians’ attitudes toward dabigatran after a safety advisory in a specialized hospital for cardiovascular care in Japan-Reference-Cited by-同舟云学术

“Blue letter effects”: Changes in physicians’ attitudes toward dabigatran after a safety advisory in a specialized hospital for cardiovascular care in Japan

Published:2013-12 Issue:6 Volume:62 Page:366-373
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Suzuki Shinya,Sagara Koichi,Otsuka Takayuki,Kano Hiroto,Matsuno Shunsuke,Takai Hideaki,Uejima Tokuhisa,Oikawa Yuji,Koike Akira,Nagashima Kazuyuki,Kirigaya Hajime,Yajima Junji,Tanabe Hiroaki,Sawada Hitoshi,Aizawa Tadanori,Yamashita Takeshi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association;Camm;Eur Heart J,2012

2. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a Science Advisory for Healthcare Professionals from the American Heart Association/American Stroke Association;Furie;Stroke,2012

3. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008);Guidelines JCS;Circ J,2010

4. Frontiers of anticoagulation therapy for atrial fibrillation;Yamashita;J Cardiol,2011

5. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation – the J-RHYTHM Registry study design;Atarashi;J Cardiol,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmarket safety communications on drugs approved in Japan: A 25‐year analysis;Clinical and Translational Science;2024-04

2. A Survey of the Use of Direct Oral Anticoagulants in Patients' Possession at the Time of Hospitalization;YAKUGAKU ZASSHI;2021-08-01

3. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease;Thrombosis and Haemostasis;2019-07-22

4. Recurrent ischemic stroke in atrial fibrillation with non-vitamin K antagonist oral anticoagulation;Journal of Clinical Neuroscience;2019-06

5. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients—Analysis of Pharmaceuticals and Medical Devices Agency Data;Journal of Stroke and Cerebrovascular Diseases;2017-06